ADIPOQ and Insulin resistance: In overweight or obese subjects with a BMI ≥ 28 kg/m2, T2DM is associated with increased insulin resistance, increased liver fat and stiffness, and reduced adiponectin levels compared to non-diabetic subjects independent from NGT or IGT.